Comparative analyses define differences between BHD-associated renal tumour and sporadic chromophobe renal cell carcinoma.
Jikuya R, Johnson TA, Maejima K, An J, Ju YS, Lee H, Ha K, Song W, Kim Y, Okawa Y, Sasagawa S, Kanazashi Y, Fujita M, Imoto S, Mitome T, Ohtake S, Noguchi G, Kawaura S, Iribe Y, Aomori K, Tatenuma T, Komeya M, Ito H, Ito Y, Muraoka K, Furuya M, Kato I, Fujii S, Hamanoue H, Tamura T, Baba M, Suda T, Kodama T, Makiyama K, Yao M, Shuch BM, Ricketts CJ, Schmidt LS, Linehan WM, Nakagawa H, Hasumi H.
Jikuya R, et al.
EBioMedicine. 2023 Jun;92:104596. doi: 10.1016/j.ebiom.2023.104596. Epub 2023 May 12.
EBioMedicine. 2023.
PMID: 37182269
Free PMC article.
BACKGROUND: Birt-Hogg-Dube (BHD) syndrome, caused by germline alteration of folliculin (FLCN) gene, develops hybrid oncocytic/chromophobe tumour (HOCT) and chromophobe renal cell carcinoma (ChRCC), whereas sporadic ChRCC does not harbor FLCN alteration …
BACKGROUND: Birt-Hogg-Dube (BHD) syndrome, caused by germline alteration of folliculin (FLCN) gene, develops hyb …